These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 349438)

  • 1. Oral contraceptive potencies and side effects.
    Berger GS; Talwar PP
    Obstet Gynecol; 1978 May; 51(5):545-7. PubMed ID: 349438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of Norinyl 1/35 versus Lo-Ovral in Ile-Ife Nigeria.
    Ayangade O; Akinyemi A
    Int J Gynaecol Obstet; 1989 Oct; 30(2):165-70. PubMed ID: 2572488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized double blind study of two oral contraceptives.
    Sanhueza H; Sivin I; Kumar S; Kessler M; Carrasco A; Yee J
    Contraception; 1979 Jul; 20(1):29-48. PubMed ID: 477315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative trials of low-dose combined oral contraceptives.
    Edelman DA; Kothenbeutel R; Levinski MJ; Kelly SE
    J Reprod Med; 1983 Mar; 28(3):195-200. PubMed ID: 6854550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The probability of side effects with ovral, norinyl 1/50 and norlestrin.
    Berger GS; Edelman DA; Talwar PP
    Contraception; 1979 Nov; 20(5):447-53. PubMed ID: 160860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
    Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
    N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An assessment of the side effects of switching from one oral contraceptive to another.
    Edelman DA; Kothenbeutel R; Levinski MJ; Talwar PP
    Int J Gynaecol Obstet; 1976; 14(5):397-400. PubMed ID: 15904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of Norinyl and Brevicon in three sites in Sri Lanka.
    Basnayake S; de Silva SV; Miller PC; Rogers S
    Contraception; 1983 May; 27(5):453-64. PubMed ID: 6884024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of fertility with oral medication.
    Diddle AW; Watts GF; Gardner WH; Williamson PJ
    West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A quantitative study of the pregnancy zone protein in sera of woman taking oral contraceptives.
    Damber MG; von Schoultz B; Solheim F; Stigbrand T
    Am J Obstet Gynecol; 1976 Feb; 124(3):289-92. PubMed ID: 55075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sri Lanka pill and vitamin trial produces important data.
    Netw Res Triangle Park N C; 1981 Oct; 3(1):1-2. PubMed ID: 12263432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of kind of carbohydrate in the diet and use of oral contraceptives on metabolism of young women. I. Blood and urinary lactate, uric acid, and phosphorus.
    Kelsay JL; Behall KM; Moser PB; Prather ES
    Am J Clin Nutr; 1977 Dec; 30(12):2016-22. PubMed ID: 930871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of oral contraceptives on nutrients. III. Vitamins B6, B12, and folic acid.
    Prasad AS; Lei KY; Moghissi KS; Stryker JC; Oberleas D
    Am J Obstet Gynecol; 1976 Aug; 125(8):1063-9. PubMed ID: 952302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
    Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of oral contraceptive agents on nutrients: II. Vitamins.
    Prasad AS; Oberleas D; Moghissi KS; Stryker JC; Lei KY
    Am J Clin Nutr; 1975 Apr; 28(4):385-91. PubMed ID: 1168019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of contraceptive pills and intrauterine devices on urinary bladder.
    Zahran MM; Osman MI; Kamel M; Fayad M; Mooro H; Youssef AF
    Urology; 1976 Dec; 8(6):567-74. PubMed ID: 793141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum lipids and lipoproteins during treatment with oral contraceptives containing natural and synthetic oestrogens. A controlled double-blind investigation.
    Bostofte E; Hemmingsen L; Møller KJ; Serup J; Weber T
    Acta Endocrinol (Copenh); 1978 Apr; 87(4):855-64. PubMed ID: 347855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
    Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
    Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of contraceptive steroids on hypothalamic-pituitary function.
    Mishell DR; Kletzky OA; Brenner PF; Roy S; Nicoloff J
    Am J Obstet Gynecol; 1977 May; 128(1):60-74. PubMed ID: 403765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.